Zofran | The American Association For Justice

Zofran

Description:

The anti-nausea drug Zofran (ondansetron), which was approved to treat nausea and vomiting in post-surgical and cancer patients, has been prescribed off-label to pregnant women to treat morning sickness. It has not been approved for use in pregnant women, and  has been linked to doubled risks of heart defects and serious illness in newborns.

The Zofran Litigation Group educates members about Zofran; provides members with clients suffering from related conditions with work product and documents, including pleadings, discovery, and legal research; and provides a venue for networking and brainstorming ideas about how to best represent clients.

The Litigation Group provides member benefits such as a document library, including pleadings, discovery, legal research. and medical literature; a members-only list server; educational programs; and closed members-only meetings. The Group also hosts webinars, seminars in advance of JPML hearings, and other programs.

Background:

This Litigation Group was started in February 2015.

Cochairs:
Kimberly D. Barone Baden
Motley Rice LLC
28 Bridgeside Blvd
Mt. Pleasant, SC 29464
Phone: 843/216-9265
Fax: 843/216-9450
 
Elizabeth Graham
Grant & Eisenhofer PA
123 S. Justison St., 7th Floor
Wilmington, DE 19801
Phone: 302/662-7070
Fax: 302/622-7100
 
Robert K. Jenner
Jenner Law Firm
1829 Reistertown Rd., Ste. 350
Baltimore, MD 21208
Phone: 410/653-3200
PDF Application:
Dues:
$300/first attorney; $100/others in same firm